Canopy Growth posts 22% Q2 FY2027 revenue rise, eyes positive adjusted EBITDA
Canopy Growth reported consolidated net revenue of $81.4 million for the second quarter of fiscal 2027, a 22% year‑over‑year increase. Cannabis segment revenue grew 30% to $66.2 million, driven by an 18% rise in Canadian medical sales, a 17% rise in Canadian adult‑use sales, and a 141% jump in international markets to $12.3 million. Adjusted EBITDA loss narrowed to $2.9 million and the company said it expects to achieve positive adjusted EBITDA in the second half of FY2027.
Why it matters
The CFO said the improved earnings trajectory puts the company on track to generate positive adjusted EBITDA in H2 FY2027, which could support cash‑flow generation and reduce financing needs. Analysts note the strong international growth offsets headwinds in Canada, suggesting upside potential for the stock.
Key facts
- 1Consolidated net revenue was $81.4 million, up 22% YoY. nugget.ca
- 2Cannabis net revenue was $66.2 million, up 30% YoY. nugget.ca
- 3Canada medical cannabis net revenue was $25.8 million, up 18% YoY. nugget.ca
- 4Canada adult‑use cannabis net revenue was $28.1 million, up 17% YoY. nugget.ca
- 5International markets cannabis net revenue was $12.3 million, up 141% YoY. nugget.ca
- 6Adjusted EBITDA loss was $2.9 million, an improvement of $0.2 million (6%). nugget.ca
Open questions
- Storz & Bickel net revenue is reported as $15.1 million (down 4%) in material 4 and $50.1 million (down 44%) in material 9, a conflict on the same metric for the same period.
Summary written by AlphAI AI Desk from 9 of 9 sources. Not investment advice. Figures are as stated by the linked sources.